Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments

    Recruiting

    1 1
    Germany
  • A long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome

    Recruiting

    1 1 1
    Investigated drugs:
    Germany
  • A study to compare the effectiveness of rituximab and a placebo in patients with interstitial lung disease associated with rheumatoid arthritis

    Recruiting

    1 1 1
    Investigated drugs:
    Sweden
  • A study testing tulisokibart for people with rheumatoid arthritis who have not responded well enough to previous treatments

    Recruiting

    Investigated drugs:
    Germany Poland Spain
  • Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren’s disease

    Recruiting

    1 1 1
    Bulgaria France Germany Italy Poland Portugal +2
  • Study of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity

    Recruiting

    1 1 1 1
    The Netherlands
  • Study of lutikizumab and ravagalimab in adults with moderate to severe rheumatoid arthritis

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Czechia Germany Hungary Poland Slovakia Spain
  • Study on the Safety and Effects of Rapcabtagene Autoleucel, Tocilizumab, Fludarabine Phosphate, and Cyclophosphamide for Patients with Rheumatoid Arthritis and Sjogren’s Disease

    Recruiting

    1 1 1
    France Germany Hungary Italy Spain
  • Study on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Abatacept for Predicting Treatment Response in Patients with Early Rheumatoid Arthritis

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Italy The Netherlands Portugal Spain